Get the Stockscreener App
25.05
4.51%
-1.13
After Hours:
25.05
Caredx Inc stock is traded at $25.05, with a volume of 733.73K.
It is down -4.51% in the last 24 hours and up +15.58% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$26.18
Open:
$26.23
24h Volume:
733.73K
Relative Volume:
0.95
Market Cap:
$1.29B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-162.56
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
+3.82%
1M Performance:
+15.58%
6M Performance:
+24.87%
1Y Performance:
+31.30%
1-Day Range:
$24.90
$26.78
1-Week Range:
$23.00
$26.78
52-Week Range:
$10.96
$26.78
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
25.05 | 1.35B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
464.04 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.22 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
545.72 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
126.50 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
358.24 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Caredx Inc stock hits 52-week high at 26.7 USD - Investing.com
CareDx's CEO Sells 17K Shares - Yahoo Finance
Responsive Playbooks and the CDNA Inflection - Stock Traders Daily
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests - ChartMill
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Yahoo Finance
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CareDx Inc (CDNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CareDx Inc (CDNA) Institutional Confidence - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Showcases Innovations at American Transplant Congr - GuruFocus
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
CareDx Inc (CDNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CareDx presents transplant monitoring data at medical congress - Investing.com
CareDx presents transplant monitoring data at medical congress By Investing.com - Investing.com Canada
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Business Wire
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan - Stock Titan
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - BioSpace
Insider Sell: Hannah Valantine Sells 12,103 Shares of CareDx Inc (CDNA) - GuruFocus
CareDx director Hannah Valantine sells $279,728 in stock By Investing.com - Investing.com India
CareDx director Hannah Valantine sells $279,728 in stock - Investing.com UK
New Analysis from CareDx (CDNA) Highlights Allograft Outcomes - GuruFocus
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
Caredx Insider Sold Shares Worth $279,728, According to a Recent SEC Filing - marketscreener.com
CareDx (CDNA) director logs RSU grant and pre-planned share sale - Stock Titan
CareDx (CDNA) director receives 9,795-share RSU grant, holdings reach 58,943 - Stock Titan
CareDx (NASDAQ: CDNA) grants 9,795 RSUs to board member Riggsbee - Stock Titan
CareDx (CDNA) director Fred E. Cohen receives 9,795-share RSU grant - Stock Titan
CareDx (CDNA) director receives 9,795 RSUs in equity grant - Stock Titan
Director George Bickerstaff receives 9,795 RSUs at CareDx (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) director awarded 9,795 restricted stock units - Stock Titan
CareDx Shareholders Back Directors, Auditor and Equity Plan - The Globe and Mail
CareDx study links kidney test elevations to graft loss risk By Investing.com - Investing.com Nigeria
CareDx study links kidney test elevations to graft loss risk - Investing.com UK
CareDx sharpens precision diagnostics push with Naveris deal, AlloHeme plans - MSN
CareDx, Inc. Approves Amendment to 2024 Equity Incentive Plan and Reports 2026 Annual Meeting Results - Minichart
CareDx president and CEO John Hanna sells $528,442 in company stock - Investing.com India
CareDx president and CEO John Hanna sells $528,442 in company stock By Investing.com - Investing.com South Africa
CareDx shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com Nigeria
Caredx Insider Sold Shares Worth $528,443, According to a Recent SEC Filing - Moomoo
CareDx (CDNA) CEO logs 21,998-share open-market stock sale - Stock Titan
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx (NASDAQ: CDNA) shareholders approve equity plan increase and board slate - Stock Titan
CareDx rebounds as draft LCD suggests no change in coverage - MSN
Caredx Inc stock hits 52-week high at $24.04 By Investing.com - Investing.com Nigeria
CareDx (CDNA) Q1 2026 Earnings: Strong EPS Beat Driven by Operational EfficiencyEarnings Risk Report - newsline.com
CareDx highlights 39% Q1 growth, Naveris oncology push at Jefferies - MSN
CareDx Inc (CDNA) Stock Price, Trades & News - GuruFocus
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Valantine Hannah | Director |
Jun 15 '26 |
Sale |
23.11 |
12,103 |
279,728 |
36,686 |
| Hanna John Walter JR | President and CEO |
Jun 11 '26 |
Sale |
24.02 |
21,998 |
528,443 |
649,642 |
0.59%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):